Mason & Associates (California)’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,060
Closed -$245K 116
2024
Q3
$245K Buy
+2,060
New +$245K 0.06% 101